Erik A. Nelson

3.1k total citations · 1 hit paper
38 papers, 2.3k citations indexed

About

Erik A. Nelson is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Erik A. Nelson has authored 38 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 17 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Erik A. Nelson's work include Cytokine Signaling Pathways and Interactions (13 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Acute Myeloid Leukemia Research (10 papers). Erik A. Nelson is often cited by papers focused on Cytokine Signaling Pathways and Interactions (13 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Acute Myeloid Leukemia Research (10 papers). Erik A. Nelson collaborates with scholars based in United States, China and Switzerland. Erik A. Nelson's co-authors include David A. Frank, Sarah R. Walker, Fabrice Porcheray, Mehrdad Mohseni, Christine Canning, Robert J. Soiffer, Emmanuel Zorn, Roberto Bellucci, Jerome Ritz and Elke Raderschall and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Erik A. Nelson

38 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

2006 601 citations Erik A. Nelson, David A. Frank et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik A. Nelson United States	23	907	887	869	530	299	38	2.3k
Michel Jourdan France	29	1.5k 1.7×	906 1.0×	829 1.0×	1.1k 2.1×	235 0.8×	54	2.9k
Sachiko Ezoe Japan	23	874 1.0×	607 0.7×	723 0.8×	423 0.8×	228 0.8×	55	2.0k
Don M. Wojchowski United States	32	1.2k 1.3×	804 0.9×	613 0.7×	825 1.6×	442 1.5×	95	2.7k
Brent L. Kreider United States	26	1.4k 1.5×	1.1k 1.3×	1.1k 1.3×	420 0.8×	155 0.5×	44	2.9k
Miriam Erlacher Germany	23	1.6k 1.7×	561 0.6×	641 0.7×	330 0.6×	173 0.6×	78	2.5k
Cassandra J. Vandenberg Australia	19	2.2k 2.4×	912 1.0×	553 0.6×	301 0.6×	268 0.9×	44	2.9k
Daniela Ungureanu Finland	23	1000 1.1×	886 1.0×	664 0.8×	274 0.5×	479 1.6×	51	2.1k
Jiro Kikuchi Japan	27	1.5k 1.6×	594 0.7×	352 0.4×	685 1.3×	153 0.5×	89	2.2k
Leonie A. Cluse Australia	18	1.7k 1.8×	884 1.0×	638 0.7×	279 0.5×	149 0.5×	21	2.4k
Robyn Catlett-Falcone United States	6	1.3k 1.4×	1.6k 1.9×	684 0.8×	315 0.6×	217 0.7×	8	2.4k

Countries citing papers authored by Erik A. Nelson

Since Specialization

Citations

This map shows the geographic impact of Erik A. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Nelson more than expected).

Fields of papers citing papers by Erik A. Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Nelson. The network helps show where Erik A. Nelson may publish in the future.

Co-authorship network of co-authors of Erik A. Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Nelson. A scholar is included among the top collaborators of Erik A. Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Nelson. Erik A. Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Egusquiaguirre, Susana P., Suhu Liu, Sarah R. Walker, et al.. (2019). CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3. Neoplasia. 22(1). 47–59. 14 indexed citations

Weisberg, Ellen, Atsushi Nonami, Chen Zhao, et al.. (2014). Upregulation of IGF1R by Mutant RAS in Leukemia and Potentiation of RAS Signaling Inhibitors by Small-Molecule Inhibition of IGF1R. Clinical Cancer Research. 20(21). 5483–5495. 14 indexed citations

Liu, Suhu, Sarah R. Walker, Erik A. Nelson, et al.. (2014). Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2. Molecular Cancer Therapeutics. 13(5). 1194–1205. 51 indexed citations

Weisberg, Ellen, Atsushi Nonami, F. Liu, et al.. (2014). Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies. Leukemia. 29(1). 27–37. 49 indexed citations

Granja, Tiago, D. Köhler, Valbona Mirakaj, et al.. (2013). Crucial role of Plexin C1 for pulmonary inflammation and survival during lung injury. Mucosal Immunology. 7(4). 879–891. 22 indexed citations

Walker, Sarah R., Erik A. Nelson, Jennifer Yeh, et al.. (2013). STAT5 Outcompetes STAT3 To Regulate the Expression of the Oncogenic Transcriptional Modulator BCL6. Molecular and Cellular Biology. 33(15). 2879–2890. 69 indexed citations

Weisberg, Ellen, Qingsong Liu, Xin Zhang, et al.. (2013). Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells. PLoS ONE. 8(2). e56473–e56473. 37 indexed citations

Bar‐Natan, Michal, Erik A. Nelson, Michael Xiang, & David A. Frank. (2012). STAT signaling in the pathogenesis and treatment of myeloid malignancies. PubMed. 1(2). 55–64. 70 indexed citations

Deng, Xianming, Wenjun Zhou, Ellen Weisberg, et al.. (2012). An amino-indazole scaffold with spectrum selective kinase inhibition of FLT3, PDGFRα and kit. Bioorganic & Medicinal Chemistry Letters. 22(14). 4579–4584. 12 indexed citations

10.

Weisberg, Ellen, Qingsong Liu, Erik A. Nelson, et al.. (2012). Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors. Leukemia. 26(10). 2233–2244. 61 indexed citations

11.

Weisberg, Ellen, Arghya Ray, Erik A. Nelson, et al.. (2011). Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells. PLoS ONE. 6(9). e25351–e25351. 38 indexed citations

12.

Takakura, Ayumi, Erik A. Nelson, Benjamin D. Humphreys, et al.. (2011). Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Human Molecular Genetics. 20(21). 4143–4154. 107 indexed citations

13.

Nelson, Erik A., Sreenath V. Sharma, Jeffrey Settleman, & David A. Frank. (2011). A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation. Oncotarget. 2(6). 518–524. 71 indexed citations

14.

Weisberg, Ellen, Hwan Geun Choi, Rosemary Barrett, et al.. (2010). Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors. Molecular Cancer Therapeutics. 9(9). 2468–2477. 12 indexed citations

15.

Walker, Sarah R., et al.. (2010). Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling. Molecular Pharmacology. 78(5). 903–908. 54 indexed citations

16.

Weisberg, Ellen, Arghya Ray, Rosemary Barrett, et al.. (2010). Smac mimetics: implications for enhancement of targeted therapies in leukemia. Leukemia. 24(12). 2100–2109. 76 indexed citations

17.

Walker, Sarah R., Erik A. Nelson, Lihua Zou, et al.. (2009). Reciprocal Effects of STAT5 and STAT3 in Breast Cancer. Molecular Cancer Research. 7(6). 966–976. 107 indexed citations

18.

Walker, Sarah R., Erik A. Nelson, & David A. Frank. (2006). STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene. 26(2). 224–233. 91 indexed citations

19.

Nelson, Erik A., et al.. (2006). Identification of Human STAT5-dependent Gene Regulatory Elements Based on Interspecies Homology. Journal of Biological Chemistry. 281(36). 26216–26224. 22 indexed citations

20.

Nelson, Erik A., Sarah R. Walker, James V. Alvarez, & David A. Frank. (2004). Isolation of Unique STAT5 Targets by Chromatin Immunoprecipitation-based Gene Identification. Journal of Biological Chemistry. 279(52). 54724–54730. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact